173 related articles for article (PubMed ID: 34008925)
1. Low-grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw.
Sasaki A; Miyashita H; Kawaida M; Kameyama K
Clin Exp Dent Res; 2021 Dec; 7(6):1175-1182. PubMed ID: 34008925
[TBL] [Abstract][Full Text] [Related]
2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
3. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
4. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
5. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.
Hayashi K; Tsuchiya H; Yamamoto N; Shirai T; Nishida H; Takeuchi A; Kimura H; Miwa S; Inatani H; Okamoto H; Yamada S; Ikeda H; Sawada-Kitamura S; Nojima T; Ooi A; Otsuka T
Int J Clin Oncol; 2014 Aug; 19(4):731-8. PubMed ID: 23881556
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcomas of jaw: experience of a single centre.
Argon A; Doğanavşargıl B; Ünal Yıldırım F; Sezak M; Midilli R; Öztop F
J Plast Surg Hand Surg; 2015 Feb; 49(1):13-8. PubMed ID: 24780088
[TBL] [Abstract][Full Text] [Related]
10. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
11. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
[TBL] [Abstract][Full Text] [Related]
12. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
[TBL] [Abstract][Full Text] [Related]
13. [Pathomorphology of parosteal osteosarcoma. Experience with 125 cases in the Hamburg Register of Bone Tumors].
Delling G; Werner M
Orthopade; 2003 Jan; 32(1):74-81. PubMed ID: 12557089
[TBL] [Abstract][Full Text] [Related]
14. Parosteal osteosarcoma.
Hang JF; Chen PC
Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
16. Gnathic osteosarcomas, experience of four institutions from Turkey.
Yildiz FR; Avci A; Dereci O; Erol B; Celasun B; Gunhan O
Int J Clin Exp Pathol; 2014; 7(6):2800-8. PubMed ID: 25031699
[TBL] [Abstract][Full Text] [Related]
17. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
18. Gnathic osteosarcomas: a 10-year multi-center demographic study.
Azizi T; Motamedi MH; Jafari SM
Indian J Cancer; 2009; 46(3):231-3. PubMed ID: 19574676
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature review.
de la Guardia V; O'Meally AA; Gambarotti M; Spinnato P; Frisoni T; Cocchi S; Magagnoli G; Ibrahim T; Benini S; Pacheco M; Righi A
Pathol Res Pract; 2023 Feb; 242():154326. PubMed ID: 36716613
[TBL] [Abstract][Full Text] [Related]
20. High-grade surface osteosarcomas.
Wold LE; Unni KK; Beabout JW; Pritchard DJ
Am J Surg Pathol; 1984 Mar; 8(3):181-6. PubMed ID: 6584042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
